莫沙必利与埃索美拉唑联合治疗反流性食管炎的疗效分析

Study on Mosapride Combined With Esomeprazole Treatment Effect for Reflux Esophagitis

目的分析莫沙必利与埃索美拉唑联合治疗反流性食管炎效果。方法研究2015年2月-2015年10月纳入反流性食管炎患者共53例,按数字法将其分组。莫沙必利与铝碳酸镁治疗26例,此为对照组;莫沙必利与埃索美拉唑治疗27例,此为实验组,组间比较。结果两组中实验组的症状评分下降明显,治疗有效率低,差异具有统计学意义（P〈0.05）。结论治疗反流性食管炎时,选用莫沙必利与埃索美拉唑联合治疗,效果确切。

Objective Mosapride combined with esomeprazole treatment effect for reflux esophagitis is to be studied. Methods Chose 53 patients of reflux esophagitis who are treated in hospital from February 2015 to October 2015 and separate them into two groups according to digits,26 patients in control group are given mosapride combined with hydrotalcite treatment,while another 27 patients in study group are given mosapride combined with esomeprazole treatment,and then compare treatment effects between two groups. Results Patients＇ symptoms assessment scores in study group are reduced dramatically and treatment efficacy is much higher,there is a differential between two groups and such a differential has statistic value（P〈0.05）. Conclusion Mosapride combined with esomeprazole treatment is effective for reflux esophagitis.